Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Flagship

ESPN Lands On Disney+ in Major Content Fusion: Here's What It Actually Means

Disney+ has expanded its sports content by integrating ESPN, offering bundled and standalone subscribers access to live events and ESPN+ programming, while setting the stage for ESPN's direct-to-consumer Flagship service launch in 2025.

Benzinga

The ‘flagship office’ is on the rise—and it uses the principles of the experience economy to coax employees back to their desks

These carefully redesigned built environments, compelling stories, and authentic experiences would in fact be well worth an admission fee.

Fortune

3 men arrested after a woman in a swimsuit was found shot dead and left in the rocks along the Atlantic City beach

Security footage shows five people walking toward the scene of the murder on the night it happened, but only two people returning

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Pinarello Factory tech gallery: A glimpse at Fausto Pinarello's private collection

Images from a recent visit to the Pinarello flagship store and factory itself as well as some very special bikes

Cycling News

For Flagship, Moderna’s COVID-19 vaccine is a tough act to follow

Unorthodox, brash, and sometimes controversial, Flagship Pioneering is looking for its next blockbuster.

Fortune

Are Pfizer (PFE) and AbbVie (ABBV) Good Value Buys for August?

The pharma industry is poised to witness long-term growth with the introduction of generic medicines and growing demand for personalized and targeted treatments. Hence, fundamentally strong pharma stock AbbVie (ABBV) might be worth buying. However, it might not be the right time to invest in Pfizer (PFE). Keep reading.

StockNews.com

Is AbbVie (ABBV) a Better Stock to Buy Than Pfizer (PFE)?

Due to the emergence of new technologies and the introduction of generic medicines, the pharma industry seems well-positioned to witness growth. While pharma stocks should benefit from the industry tailwinds, let us analyze whether AbbVie (ABBV) is a better buy than Pfizer (PFE).

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

Pfizer and Moderna parent are investing $100M to find the next big drug

"What we are doing now, I don’t think anyone has done so far," Pfizer CEO Albert Bourla says.

Fortune

The new Longines Flagship Heritage is a timelessly elegant wristwatch

Longines is offered three versions, all with a moon phase complication on the dial

It's Time? ESPN Making Real Plans to Stream 'Flagship' Cable Channel Direct-to-Consumer

Two weeks ago, ESPN Chairman Jimmy Pitaro said ESPN would become a standalone streaming destination 'when it makes sense.' After several reports of epic Q1 cord-cutting, that time might just have arrived

Broadcasting & Cable

The Legend of Zelda: Oracle of Ages and Seasons retrospective

How Capcom's first field trip into the world of Zelda left a lasting influence on the series that can be felt today

GamesRadar

Biogen, Seagen Name New CEOs — But One Biotech Stock Crumbles

Biogen and Seagen tapped new CEOs on Thursday but the biotech stocks diverged following the long-anticipated announcements.

Investors Business Daily

Bangor Flagship: First look inside city's planned new food market

"Subject to planning, we're going to have capacity for 280 customers so plenty of footfall to take advantage of!"

Belfast Live

Bangor Flagship: New plans set to include food market

"Bringing lots of different hot food kitchen options under one roof, this will hopefully be a great foodie destination for the people of Northern Ireland."

Belfast Live

Get all your
news in one place.

100’s of premium titles.
One news app.

Belfast Live

Revamp of iconic Co Down shopping centre puts firm focus on local shops and traders

Bangor outlet looks to set sail again as the Flagship Arcade

Investors Business Daily

AbbVie Stock Breaks Its Stride As Key Executive Departs For Flagship

AbbVie stock crumbled Wednesday after the company announced President and Vice Chairman Michael Severino will depart at the end of May.

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.